Johnson & Johnson unit settles patent dispute over hypertension drug

In a win for Johnson & Johnson, its Actelion unit has settled an infringement lawsuit after generic drug maker Laurus conceded that a patent for a pulmonary hypertension drug was valid.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Covidien wins patent suit against Johnson & Johnson owned company

29 January 2014 Healthcare company Covidien PLC has been told it did not infringe patents belonging to a Johnson & Johnson-owned company through using its ultrasonic dissection device.

Americas

Federal Circuit backs PTAB in Johnson & Johnson patent appeal

4 January 2017 The US Court of Appeals for the Federal Circuit has affirmed a Patent Trial and Appeal Board decision that said patent claims owned by Ethicon, a subsidiary of Johnson & Johnson (J&J), are invalid.

More on this story

Americas

Covidien wins patent suit against Johnson & Johnson owned company

29 January 2014 Healthcare company Covidien PLC has been told it did not infringe patents belonging to a Johnson & Johnson-owned company through using its ultrasonic dissection device.

Americas

Federal Circuit backs PTAB in Johnson & Johnson patent appeal

More on this story

Americas

Covidien wins patent suit against Johnson & Johnson owned company

29 January 2014 Healthcare company Covidien PLC has been told it did not infringe patents belonging to a Johnson & Johnson-owned company through using its ultrasonic dissection device.

Americas

Federal Circuit backs PTAB in Johnson & Johnson patent appeal